Becker’s Payer Issues

publications Summer 2024 Prime Therapeutics Report June 11, 2024 The Prime Therapeutics Report is your source for innovative managed care strategies, trends and updates. This issue’s cover story...

Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage

cover image for Drug Approvals: November 2024 Critical updates in an ever-changing environment Prime Therapeutics /drug-approvals-november-2024 Prime Therapeutics’ Drug Approvals provides an...

cover image Drug Approvals: April 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

Drug Approvals Quarterly Update: October 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process. Prime...

Cover image for Drug Approvals: July 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

Cover image for Drug Approvals: March 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

Cover image for Drug Approvals: February 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

Cover image for Summer 2024 Prime Therapeutics Report Pulmonary arterial hypertension: Exciting new approval and payer impact Prime Therapeutics /2024-summer-prime-therapeutics-report The Prime...

Hear the first part of a two-part preview of the research the Prime Therapeutics health outcomes team will present at the annual managed care pharmacy event

Jessica Johnson, clinical consultant at Prime's Special Investigations Unit, shares tips to stay safe when using online pharmacies

Corporate Equality Index is a prominent benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality

Our journey to reimagine pharmacy We are fueled by the desire to deliver an intuitive, meaningful, affordable experience that customers and members appreciate. By combining our innovation and...

Recognition benchmarks disability workplace inclusion against other companies

Discover the latest trends and emerging strategies to manage rising medical benefit specialty drug spend.

Perspectives Expert Clinical Network Insights: June 2024 A look into our Expert Clinical Network (ECN) — part of Prime/MRx’s value-based approach to medical and pharmacy benefit management that...

From cutting-edge system solutions to powerful stakeholder partnerships, the Medicaid Enterprise Systems Conference delivered key insights and connections that will shape health care modernization...

Researchers share insights on accelerated approvals, health equity in food allergies and legislative impacts on sight of service

Jessica Johnson, clinical consultant at Prime, shares some tips to stay safe

Jared Scripture, health outcomes scientist, shares more about the study “Leveraging Publicly Available SDOH Measures to Segment Members and Quantify Differences in Diabetic Medication Adherence: A...

Specialty Pharmacy Continuum

AMCP Nexus offers opportunity to nurture next generation of managed care leaders

publications Quarterly Drug Approvals: July 2025 This report provides an overview of new drugs and indications approved in 2025 August 1, 2025 Specialty drug approvals Specialty drug approvals -...

publications Quarterly Drug Approvals: January 2025 This report provides an overview of new drugs and indications approved in 2024 January 31, 2025 Specialty drug approvals Specialty drug...

publications Quarterly Drug Approvals: April 2025 This report provides an overview of new drugs and indications approved in 2025 April 24, 2025 Specialty drug approvals Specialty drug approvals -...

Drug pricing information All drugs listed on the National Average Drug Acquisition Cost (NADAC) list that are reimbursed at rates either 10% below or 10% above the national average drug...

publications Quarterly Drug Approvals: October 2024 This report provides an overview of new drugs and indications approved in 2024 October 31, 2024 Specialty drug approvals Specialty drug...

Connect care for your members with cancer IntegratedRx® – Oncology puts everyone on the same team and gives members a central location for their cancer medicines. Breadcrumb Home Our solutions...

See the latest FDA drug recalls We monitor Food and Drug Administration (FDA) recall notices to keep you in the know. 2025 Aug. 30 | Sucralfate, 1 gram | Nostrum Jul. 15 | Sulfamethoxazole /...

Connect care for your members with cystic fibrosis IntegratedRx – Cystic Fibrosis helps deliver an integrated care experience for members and their providers. Breadcrumb Home Our solutions...

Provide a uniquely integrated experience More connected care helps curb costs and improve the experience for your members with cancer and cystic fibrosis. Breadcrumb Home Our solutions Specialty...

Help your members living with cystic fibrosis We support members navigating their cystic fibrosis (CF) with a holistic, customized approach to care. Breadcrumb Home Our solutions Condition...

Members on cancer care journey laud Prime’s integrated clinic-to-pharmacy experience

Support your members with asthma and COPD Our solutions help your members with asthma and chronic obstructive pulmonary disease (COPD) stay healthy. Breadcrumb Home Our solutions Condition...

Prime leaders discuss rebates, reporting and other state issues at hybrid conference in Chicago.

Care for your members living with cancer Our deep expertise and holistic view of care help your members manage their oncology drugs and simplify their experience. Breadcrumb Home Our solutions...

Experts in Medicaid pharmacy delivery engage in timely discussion of states’ access and cost challenges and offer Prime’s solutions to fill resource gaps and improve health outcomes for people...

Job-seeking platform recognizes Prime’s leadership in championing flexible work

Support your members with hemophilia We work with you to deliver thoughtful, personalized care to people with this rare bleeding disorder. Breadcrumb Home Our solutions Condition management...

publications Pancreatic cancer: Innovative therapy approved, but unmet need continues April 14, 2025 Author: Simone Ndujiuba, PharmD, BCOP In the United States, pancreatic cancer is the fourth...

Joseph Leach, M.D., senior vice president and chief medical officer at Prime Therapeutics/Magellan Rx Management, shares more about the RTBC electronic prescription decision support tool

Nondiscrimination & Languages Prime Therapeutics (Prime) complies with applicable federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability...

Benefit from effective medication management Promote appropriate medication use, decrease waste and connect the entire care journey with our GuidedHealth® solutions. Breadcrumb Home Our solutions...

Read Heading Example Heading Example Clinical News Your monthly source for drug information highlights A paragraph is a self-contained unit of a discourse in writing dealing with a particular point...

Care for your members with multiple sclerosis Our deep expertise and holistic view of patient care help us support your members with multiple sclerosis (MS). Breadcrumb Home Our solutions Condition...

Tap into a multistate purchasing pool With the National Medicaid Pooling Initiative (NMPI), we negotiate the best price available from the pharmaceutical industry on behalf of our participating...

Prime’s IntegratedRx® – Cystic Fibrosis product earns 94% member satisfaction rate

Prime Therapeutics residents, Almina Gomez and Kathryn Makay, shared their research and experiences at annual managed care pharmacy event 

Help your patients manage their condition We help empower your patients to understand and navigate their chronic conditions. Breadcrumb Home Pharmacy Specialty Pharmacy Specialty Pharmacy -...

Reprinted with AIS Health permission from the November 2024 issue of Radar on Specialty Pharmacy

Tie costs to outcomes with VBCs See how we’re reinventing the current drug payment model in Medicaid. Breadcrumb Prime Therapeutics Home Our solutions Government solutions State government...

Expert Clinical Network Insights: April 2024 A look into our Expert Clinical Network (ECN) — part of Prime/MRx’s value-based approach to medical and pharmacy benefit management that offers access...

Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies

Meredith Delk, senior vice president and general manager of state government solutions at Prime Therapeutics, shares more about the important role women play in our world today

Nicole Grevenitz, director of clinical account services, shares more from the research study “Promoting Health Equity Through Enhanced, Personalized Digital Outreach.”

Prime celebrates 25th anniversary, and Magellan Rx celebrates 10th anniversary

AIS Health

Scott Leslie, director of health outcomes, shares more about the study “Real-World Case Series Study of Spinal Muscular Atrophy Pediatric Patients Treated With Onasemnogene Abeparvovec (Zolgensma)”

A look at the specialty landscape and how Prime delivers value to employers